We deliver accelerated revenue growth by helping you prioritize activities across Marketing, Market Access, Commercial Operations, and R&D.
We have answered your call for innovative global solutions that are straight forward, effortless to use, and cost effective.
In recent years, dramatic changes have been occurring to the landscape of the US healthcare system. These changes herald both threats and opportunities for biopharma companies, and staying abreast of the new realties requires timely and integrated easy access to multiple streams of information.
EPS has developed EPS 360TM, an online healthcare stakeholder management system that assists biopharma companies develop their stakeholder strategies.
EPS 360TM connects the stakeholder relationships which exist across the US healthcare system, provides a single version of customers, breaks down existing information silos, enhances workflow and process, and improves business performance.
We help you prioritize resource allocation across key markets for pipeline and in-market brands. By identifying market opportunities and integrating evidence across the global customer landscape we help you choose risk appropriate investments that deliver quantified commercial outcomes and predictable revenue growth.
A structured and adaptable approach allows you to act quickly to capture market opportunities. Since planning is not a one time event, we provide support all year. You can easily evaluate market scenarios as changes arise.
Linking strategy to tactical implementation supports decisions which deliver quantifiable financial impact. The top-down approach integrates with your current efforts and is powered by traditional insight sources.
Now you can gain alignment across your broad team, jointly set success criteria, and produce management ready business plans quickly and affordably.
While Business Planning across markets is challenging, consistently measuring your success can be costly. Our foundational set of competitive core market metrics supports progress monitoring across the established pharmaceutical markets.
A structured and adaptable approach allows you to act quickly to capture market opportunities. Since planning is not a one time event, we provide support all year. You can easily evaluate market scenarios as changes arise.
Designed to help you prioritize activities across Marketing, Market Access, Commercial Operations, and R&D. Predictive growth metrics are being used to evaluate key investments as well as identify and transfer successful local market strategies to under performing markets.
The metrics have been designed in concert with BioPharma industry clients to decrease their major ongoing brand performance costs by 35%. Applications that are currently being supported include:
Beginning with a set of industry standard global key performance indicators (KPI) we help you select additional indicators used to support your unique business strategy. The standard global KPI set includes both financial and non-financial metrics:
By placing your customers at the center of your process it allows you to focus on exactly what truly drives your revenue growth.
Now you can look across your business with a consistent view and know that you are maximizing your customers experience now and in the future.